Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Crescent Capital BDC, Inc. CCAP

Financial — Asset Management

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
5.48
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — 3 3
Insider Ownership
4.11%

Capital & Financial Ratios

Market Cap
371.78
Revenue
156.40
Net Income
(3.17)
Free Cash Flow
39.47
Net Debt
887.20
Current Ratio
1.30
Debt/Equity
1.41
P/E ratio
0.00
P/S ratio
2.30
P/B ratio
0.55
Past 5Y EPS Growth
3.30%
This Y EPS Growth
(18.06%)
Next Y EPS Growth
(5.57%)
Next 5Y EPS Growth
(10.43%)
in millions of $

Dividends

Payout Ratio
1.89
Annual Dividend Rate
1.64
Annual Dividend Yield
10.87%
total individual payouts
2028 ‡‡‡‡‡
2027 ‡‡‡‡‡
2026 1.75
—
—
—
—
—
—
2025 2.06
—
—
—
—
—
—
—
2024 2.04
—
—
—
—
—
—
—
—
2023 1.81
—
—
—
—
—
—
2022 1.64
—
—
—
—
—
—
—
2021 1.64
—
—
—
—
—
2020 1.64
—
—
—
—
2019 ‡‡‡‡
2017 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 24.47 39.42 31.50 35.74
Receivables 14.25 12.17 17.35 8.93
Inventory — — — —
Other — — — —
38.72 51.59 48.85 44.67
2023 2024 2025 Q'26
Payables 15.20 15.57 15.53 12.53
ST’ Debt — — — —
Other — — — —
39.34 39.05 40.01 34.47
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow — ‡‡‡ ‡‡‡‡‡
Earnings — ‡‡‡‡‡ ‡‡‡‡‡
Book Value — ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 37.91 36.32 — —
—
’25 42.13 42.99 41.35 40.81
167.29
’24 50.36 48.95 51.63 46.42
197.36
’23 39.28 46.74 48.15 49.96
184.13
’22 26.38 26.77 28.99 34.57
116.72
’21 20.57 23.80 25.48 24.14
93.99
’20 18.83 19.33 18.67 20.28
77.11
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (23.80) 9.85 — —
—
’25 (15.13) 36.44 30.77 22.65
74.72
’24 39.50 (24.64) 46.94 (2.89)
58.91
’23 16.01 20.34 21.35 34.60
92.30
’22 11.17 (7.00) (18.06) 41.85
27.95
’21 (1.40) (0.71) (41.76) (113.78)
(157.65)
’20 (51.32) 38.56 (14.49) (34.55)
(61.80)
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 (23.80) 9.85 — —
—
’25 (15.13) 36.44 30.77 22.65
74.72
’24 39.50 (24.64) 46.94 (2.89)
58.91
’23 16.01 20.34 21.35 34.60
92.30
’22 11.17 (7.00) (18.06) 41.85
27.95
’21 (1.40) (0.71) (41.76) (113.78)
(157.65)
’20 (51.32) 38.56 (14.49) (34.55)
(61.80)
in millions of $

EPS

Mar Jun Sep Dec Year
’26 (0.42) (0.09) — —
—
’25 0.11 0.41 0.19 0.23
0.93
’24 0.76 0.55 0.41 0.27
1.99
’23 0.24 0.61 0.61 0.83
2.33
’22 0.52 (0.03) (0.08) 0.08
0.50
’21 0.76 1.16 0.59 0.43
2.94
’20 (2.84) 2.00 1.36 1.25
1.98

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡‡

Recommendation Rating

2.6
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — ‡‡‡‡ ‡‡‡‡‡ 12.55 12.87 15.91 13.03 — — —
Low Price
— — — — ‡‡‡‡‡ ‡‡‡‡‡ 18.71 18.00 20.03 20.19 — — —
High Price
— — — — — — — — — — — — —
Employees
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 0.00 0.00 0.00 0.00 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 116.72 184.13 197.36 167.29 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 72.69% 68.10% 68.20% 65.66% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 59.88 83.85 90.59 68.60 — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 51.31% 45.54% 45.90% 41.01% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 15.54 83.84 73.65 34.51 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (5.12) (5.17) (6.46) (3.43) — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.78 5.13 5.33 4.52 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 0.50 2.33 1.99 0.93 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.90 2.57 1.59 2.02 — — —
Cash Flow/Sh
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.90 2.57 1.59 2.02 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 19.83 20.67 19.98 19.06 — — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 30.89 35.93 37.06 37.04 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 27.10 7.52 9.66 14.95 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.51 3.36 3.61 3.11 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.67 0.83 0.96 0.74 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.98 7.81 7.85 8.15 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 37.48 15.59 26.29 18.24 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 27.95 92.30 58.91 74.72 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
— — — — — — — — — — — — —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 27.95 92.30 58.91 74.72 — — —
FCF
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (7.29) (0.62) 12.54 8.84 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 654.46 844.78 875.84 873.76 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 637.39 820.31 836.42 842.26 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 612.54 742.59 740.64 706.04 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.19% 5.72% 4.49% 2.11% — — —
ROA
‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.68% 3.35% 3.59% 2.77% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.46% 12.37% 9.93% 4.77% — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Crescent Capital BDC, Inc. (CCAP) has demonstrated impressive revenue resilience amid macroeconomic headwinds, scaling from $13.8 million in 2016 to $197.4 million in 2024—a staggering 40% CAGR—fueled by post-2019 public listing, robust deal flow, and Federal Reserve rate hikes that supercharged net interest margins on floating-rate loans. However, profitability remains volatile, with net income swinging from an 81% plunge in 2022 due to credit stress to a swift recovery exceeding $73 million in 2024, underscoring BDCs’ sensitivity to interest rate cycles and economic shocks like inflation peaks and geopolitical tensions.

Balance sheet strength supports this growth, with equity up 479% and manageable 1.2x leverage, yielding a solid 9.9% ROE and positive free cash flow for dividend coverage. Yet, per-share dilution, stabilizing book value, and recent stock underperformance—trading at a 4% discount to NAV and 9.7x trailing PE—signal caution amid looming 2025-2026 rate cuts that could erode margins and soften revenue projections by 6-8% annually through 2027.

Analysts forecast EPS volatility with 11% consensus upside (up to 36% high-end), bolstered by CCAP’s focus on resilient middle-market sectors like software and healthcare, but tempered by credit cycle risks echoing 2008-2009 scars. This undervaluation amid stabilizing fundamentals presents a compelling case for yield-seeking investors—explore the full analysis for historical parallels, detailed forecasts, and strategic navigation tips.

Read full commentary →

Crescent Capital BDC, Inc. (CCAP) Latest News

News by impact score

Fine-tune

11 Aug

3 , 7:01 PM
Crescent Capital BDC Inc's Q2 2026 earnings call showed NAV declining for the eighth consecutive period. Repeated NAV drops indicate sustained pressure on asset values and investor outlook.

3 www.marketbeat.com, 1:04 PM
Crescent Capital BDC, Inc. (CCAP) discussed its second quarter financial results and operational highlights during the earnings call. Q2 earnings highlights reveal CCAP performance metrics and strategy that moderately shape near-term investor views.

3 transcript app.moby.co, 8:30 AM
Crescent Capital BDC, Inc. held its Q2 2026 earnings call, covering financial results, portfolio performance, and forward outlook for the business development company. Earnings call delivers quarterly results and guidance that moderately influence near-term stock sentiment and valuation.

10 Aug

3 , 5:55 PM
Crescent Capital BDC (CCAP) missed Q2 earnings and revenue estimates. Missing Q2 earnings and revenue targets creates moderate negative pressure on CCAP stock and near-term investor sentiment.

14 May

4 , 7:04 PM
Crescent Capital BDC Inc (CCAP) Q1 2026 earnings call highlights strategic fee reductions to drive growth amid stable portfolio performance and positive net investment income outlook. Strategic fee reductions represent a major move to enhance competitiveness and attract capital, significantly impacting future performance and investor sentiment.

4 www.marketbeat.com, 1:09 PM
Crescent Capital BDC (CCAP) reported Q1 earnings call highlights, including net investment income of $0.37 per share, a 10% portfolio yield, NAV per share at $18.45, and new investments totaling $150 million amid stable credit performance and positive outlook for sponsor-backed lending. Q1 earnings highlights detail core financial metrics, portfolio growth, and strategic lending focus directly shaping CCAP's valuation and market trajectory.

4 app.moby.co, 8:30 AM
Crescent Capital BDC, Inc. (CCAP) released Q1 2026 earnings call summary detailing financial results, portfolio performance, and future outlook. Quarterly earnings summary provides critical financial metrics, NAV changes, and dividend guidance shaping CCAP's trajectory and investor confidence.

13 May

4 Zacks, 6:45 PM
Crescent Capital BDC, Inc. (CCAP) beat Q1 earnings estimates, reporting stronger-than-expected results. Beating Q1 earnings estimates delivers significant positive signal on financial health, likely driving stock gains and enhanced investor sentiment.

4 GlobeNewswire, 5:40 PM
Crescent Capital BDC, Inc. (CCAP) reported first quarter 2026 earnings results and declared a second quarter base dividend of $0.34 per share plus a series of special dividends. Earnings announcement with base and special dividends highlights strong financial performance, poised to positively influence stock price and investor confidence.

2 Mar

4 Zacks, 12:00 PM
Analysts upgraded Crescent Capital BDC (CCAP) to Buy rating, citing strong fundamentals, attractive yield, portfolio quality improvements, and favorable market positioning. Analyst upgrade to Buy highlights improved fundamentals and yield, likely driving significant positive shifts in investor sentiment and stock performance.

3 , 9:35 AM
Crescent Capital BDC (CCAP) shares dropped 12% over four weeks amid market pressures, but undervaluation, solid portfolio performance, and high dividend yield position it for a rebound. Stock's 12% decline creates short-term sentiment drag, offset by indicators of undervaluation and operational strength signaling moderate recovery potential.

26 Feb

4 GuruFocus.com, 6:04 PM
Crescent Capital BDC Inc (CCAP) Q4 2025 earnings call highlights strong dividend coverage amid challenges, showcasing resilient financial performance. Strong dividend coverage in Q4 2025 signals financial stability, positively influencing CCAP's investor sentiment and future stock trajectory.

4 www.marketbeat.com, 3:48 PM
Crescent Capital BDC (CCAP) released key highlights from its Q4 earnings call, covering financial performance, portfolio updates, and future outlook. Q4 earnings call highlights detail financial results and guidance, likely driving significant shifts in investor sentiment and stock trajectory.

4 transcript www.fool.com, 1:19 PM
Crescent Capital BDC, Inc. (CCAP) released its earnings call transcript detailing quarterly financial results, portfolio performance, management outlook, and Q&A. Earnings transcripts disclose detailed financial metrics, dividend declarations, and strategic guidance that significantly shape CCAP's valuation and market trajectory.

4 app.moby.co, 8:30 AM
Crescent Capital BDC, Inc. (CCAP) Q4 2025 earnings call summary details financial results, portfolio performance, dividend declarations, and management outlook for the business development company. Q4 earnings call summary reveals key financial metrics and strategic insights that significantly shape CCAP's valuation and investor expectations.

25 Feb

4 Associated Press Finance, 5:08 PM
Crescent Capital BDC (CCAP) released Q4 earnings snapshot highlighting key financial metrics for the quarter. Q4 earnings directly impact financial performance, dividend sustainability, and investor sentiment for the BDC.

4 GlobeNewswire, 4:20 PM
Crescent Capital BDC, Inc. (CCAP) reported fourth quarter 2025 earnings results and declared a first quarter base dividend of $0.42 per share. Quarterly earnings release and dividend declaration provide key insights into financial health, directly affecting investor sentiment and stock trajectory.

13 Nov

3 GuruFocus.com, 6:02 PM
Crescent Capital BDC, Inc. (CCAP) reported its Q3 2025 earnings, highlighting challenges posed by tariffs affecting its operations. The company is actively navigating these issues while maintaining a focus on strategic growth and investment opportunities. Management emphasized their commitment to adapting to market conditions and optimizing their portfolio to mitigate risks associated with external economic factors. Tariff challenges are expected to moderately influence financial performance and operational strategies.

3 transcript www.fool.com, 12:52 PM
Crescent Capital BDC, Inc. (CCAP) reported its latest earnings, highlighting key financial metrics and performance indicators. The company discussed its investment strategy, portfolio performance, and outlook for the upcoming quarters. Management provided insights into market conditions and how they are navigating challenges while seeking growth opportunities. Overall, the earnings call reflected a commitment to maintaining strong returns for shareholders amidst a dynamic economic environment. Earnings performance and strategic insights may moderately influence investor sentiment and financial outlook.

12 Nov

3 Zacks, 5:40 PM
Crescent Capital BDC, Inc. (CCAP) reported its Q3 earnings, missing both earnings and revenue estimates. The company faced challenges that impacted its financial performance, leading to concerns among investors about its future trajectory. Missing earnings and revenue estimates may moderately affect investor sentiment and financial performance.

3 Associated Press Finance, 4:37 PM
Crescent Capital BDC, Inc. (CCAP) reported its Q3 earnings, showcasing a solid performance with increased net investment income and a stable portfolio. The company highlighted its strategic focus on maintaining credit quality while pursuing growth opportunities in the current market environment. Management expressed optimism about future prospects, citing favorable market conditions and a robust pipeline of investment opportunities. Overall, the earnings report reflects a positive trajectory for CCAP amidst ongoing economic challenges. The earnings report indicates moderate improvements in financial performance and strategic positioning, but broader market conditions may limit the overall impact.

3 GlobeNewswire, 4:15 PM
Crescent Capital BDC, Inc. reported its earnings results for the third quarter of 2025, highlighting a solid financial performance. The company declared a fourth quarter base dividend of $0.42 per share, reflecting its commitment to returning value to shareholders. The earnings report indicates stable operations and a positive outlook for the upcoming quarter. The earnings report and dividend declaration indicate a moderately positive influence on financial performance and investor sentiment.

5 Nov

3 Zacks, 10:00 AM
Analysts predict that Crescent Capital BDC, Inc. (CCAP) will experience a decline in earnings in the upcoming report. Factors contributing to this forecast include market conditions and potential challenges in the company's investment portfolio. Investors are advised to monitor key indicators and management's commentary during the earnings call for insights into future performance and strategic adjustments. A decline in earnings could moderately influence investor sentiment and financial performance.

4 Nov

3 Business Wire, 3:01 PM
KBRA has assigned a rating to Crescent Capital BDC, Inc.'s $185 million senior unsecured notes, which are due in 2029 and 2031. This rating reflects the company's creditworthiness and the expected performance of these financial instruments in the market. The assigned rating indicates a moderately noticeable influence on Crescent Capital BDC's financial performance and market perception.

22 Aug

3 , 3:14 PM
Options trading activity for Crescent Capital BDC, Inc. (CCAP) indicates a potential spike in the stock price, with a notable increase in call options volume. This surge suggests that investors are anticipating a significant upward movement in the stock, reflecting bullish sentiment. Analysts are closely monitoring these trends as they could signal upcoming positive developments for the company. Increased options activity may influence market sentiment and short-term stock performance.

15 Aug

4 transcript GuruFocus.com, 3:21 AM
Crescent Capital BDC, Inc. (CCAP) reported strong dividend coverage in its Q2 2025 earnings call, highlighting robust financial performance and strategic initiatives aimed at enhancing shareholder value. The company emphasized its commitment to maintaining a sustainable dividend policy while navigating market challenges. Management provided insights into portfolio performance and future growth prospects, indicating confidence in the company's ability to deliver consistent returns. Strong dividend coverage and positive financial performance indicate significant potential for future growth and investor sentiment.

13 Aug

4 GlobeNewswire, 4:20 PM
Crescent Capital BDC, Inc. reported its earnings results for the second quarter of 2025, highlighting a strong financial performance. The company declared a third quarter base dividend of $0.42 per share, reflecting its commitment to returning value to shareholders. The results indicate a positive trajectory for the firm, with potential implications for future growth and investor confidence. The declaration of a substantial dividend and strong earnings results indicate significant financial health and strategic positioning.

3 Zacks, 5:35 PM
Crescent Capital BDC, Inc. (CCAP) reported its Q2 earnings, which matched analysts' estimates. The company's performance reflects stability in its operations, maintaining investor confidence. Key financial metrics were in line with expectations, indicating a consistent approach to managing its portfolio and investments. Earnings matching estimates suggests stable performance but does not indicate significant changes in growth trajectory.

3 Associated Press Finance, 4:30 PM
Crescent Capital BDC, Inc. reported its Q2 earnings, highlighting key financial metrics and performance indicators. The company showed resilience in its portfolio management and maintained a steady dividend payout. Analysts noted the impact of market conditions on its investment strategies, while management provided insights into future growth opportunities and risk management approaches. Overall, the earnings report reflects a stable financial position amid a challenging economic landscape. The earnings report indicates moderate financial performance and strategic insights that may influence investor sentiment and operational aspects.

24 Jul

3 Insider Monkey, 11:15 PM
Crescent Capital BDC, Inc. (NASDAQ:CCAP) announced a $0.05 special dividend payable in June 2025, part of three special cash dividends totaling $0.15 for the year. The firm also declared a regular first-quarter 2025 dividend of $0.42 per share. Crescent Capital closed the year with a diversified portfolio valued at $1.6 billion, primarily in first-lien loans, with low non-accruals at 0.9% of total debt investments. The company offers a quarterly dividend yield of 12.27% as of July 23, focusing on loans to middle-market businesses to generate returns for shareholders. The announcement of special dividends and a strong portfolio indicates moderate influence on financial performance and investor sentiment.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us